Literature DB >> 8615603

Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancer.

F De Cicco Nardone1, F Rossiello, F Iacopino, M T Benedetto, B Cinque, S Dell'Acqua, G Sica.   

Abstract

Steroid receptors, prostaglandin output and enzymatic activities were determined in explants derived from human endometrium exposed to natural interferon-beta (IFN-beta). Receptors and cell metabolism were evaluated before culturing the tissue fragments and after a 3-day treatment with varying concentrations of IFN-beta. Total steroid receptor levels were unchanged when explants were set up, but there was a redistribution of both estrogen and progesterone receptors (ER and PR). A decrease in cytoplasmic receptors corresponded to an increase in receptor molecules within the nucleus. Treatment with low concentrations of IFN-beta caused a significant enhancement (p < 0.05) of ER and PR in neoplastic endometrium. In basal conditions the ratio between prostaglandin F2 alpha (Pgf2 alpha) and prostaglandin E2 (PgE2) was higher in normal than in neoplastic endometrium. The addition of low concentrations of IFN-beta to the culture medium determined a significant increase (p < 0.02) in PgF2 alpha and a parallel increase in the above ratio in neoplastic tissue, while no variation was found in normal endometrium. Analysis of the results concerning the variations in hormone-related enzymatic activities due to IFN-B revealed a significant increase (p < 0.05) in 17 beta-hydroxy-steroid-dehydrogenase (17 beta-HSD) activity. The data presented here indicate that treatment with IFN-beta modifies those biological characteristics of neoplastic cells which are involved in hormone-responsiveness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615603

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

Authors:  Valentina Tomassini; Andrea Paolillo; Pierluigi Russo; Elisabetta Giugni; Luca Prosperini; Claudio Gasperini; Guido Antonelli; Stefano Bastianello; Carlo Pozzilli
Journal:  J Neurol       Date:  2005-09-14       Impact factor: 4.849

2.  Oral contraceptives combined with interferon β in multiple sclerosis.

Authors:  Carlo Pozzilli; Laura De Giglio; Valeria T Barletta; Fabiana Marinelli; Floriana De Angelis; Valentina Gallo; Veronica A Pagano; Stefano Marini; Maria C Piattella; Valentina Tomassini; Patrizia Pantano
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.